<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36633452</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1866-0452</ISSN><JournalIssue CitedMedium="Internet"><Volume>120</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>27</Day></PubDate></JournalIssue><Title>Deutsches Arzteblatt international</Title><ISOAbbreviation>Dtsch Arztebl Int</ISOAbbreviation></Journal><ArticleTitle>Post-COVID Syndrome.</ArticleTitle><Pagination><StartPage>48</StartPage><EndPage>55</EndPage><MedlinePgn>48-55</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3238/arztebl.m2022.0409</ELocationID><ELocationID EIdType="pii" ValidYN="Y">arztebl.m2022.0409</ELocationID><Abstract><AbstractText Label="BACKGROUND">As defined by the WHO, the term post-COVID syndrome (PCS) embraces a group of symptoms that can occur following the acute phase of a SARS-CoV-2 infection and as a consequence thereof. PCS is found mainly in adults, less frequently in children and adolescents. It can develop both in patients who initially had only mild symptoms or none at all and in those who had a severe course of coronavirus disease 2019 (COVID-19).</AbstractText><AbstractText Label="METHODS">The data presented here were derived from a systematic literature review.</AbstractText><AbstractText Label="RESULTS">PCS occurs in up to 15% of unvaccinated adults infected with SARS-CoV-2. The prevalence has decreased in the most recent phase of the pandemic and is lower after vaccination. The pathogenesis of PCS has not yet been fully elucidated. Virustriggered inflammation, autoimmunity, endothelial damage (to blood vessels), and persistence of virus are thought to be causative. Owing to the broad viral tropism, different organs are involved and the symptoms vary. To date, there are hardly any evidence-based recommendations for definitive diagnosis of PCS or its treatment.</AbstractText><AbstractText Label="CONCLUSION">The gaps in our knowledge mean that better documentation of the prevalence of PCS is necessary to compile the data on which early detection, diagnosis, and treatment can be based. To ensure the best possible care of patients with PCS, regional PCS centers and networks embracing existing structures from all healthcare system sectors and providers should be set up and structured diagnosis and treatment algorithms should be established. Given the sometimes serious consequences of PCS for those affected, it seems advisable to keep the number of SARS-CoV-2 infections low by protective measures tailored to the prevailing pandemic situation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hallek</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department I of Internal Medicine, Center of Integrated Oncology ABCD, University Hospital of Cologne and German Medical Association, Berlin; Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich; Munich Chronic Fatigue Center for Young People, Children's Hospital, School of Medicine, Technical University Munich; German Society of Internal Medicine e.V. and Comprehensive Heart Failure Center, W&#xfc;rzburg; Medical Department of Infectious Diseases and Respiratory Medicine CCM/CVK/CBF, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin; Department I of Internal Medicine, Division of Infectious Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adorjan</LastName><ForeName>Kristina</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Behrends</LastName><ForeName>Uta</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Ertl</LastName><ForeName>Georg</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Suttorp</LastName><ForeName>Norbert</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Lehmann</LastName><ForeName>Clara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>on behalf of the Long COVID Working Group of the Scientific Advisory Board within the German Medical Association.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Dtsch Arztebl Int</MedlineTA><NlmUniqueID>101475967</NlmUniqueID><ISSNLinking>1866-0452</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Dtsch Arztebl Int. 2023 May 5;120(18):326. doi: 10.3238/arztebl.m2023.0094</RefSource><PMID Version="1">37485854</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>12</Day><Hour>9</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36633452</ArticleId><ArticleId IdType="pmc">PMC10060997</ArticleId><ArticleId IdType="doi">10.3238/arztebl.m2022.0409</ArticleId><ArticleId IdType="pii">arztebl.m2022.0409</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6 100122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. The Lancet. 2021;398(10302):747&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin-Chowdhury Z, Ladhani SN. Causation or confounding: why controls are critical for characterizing long COVID. Nat Med. 2021;27:1129&#x2013;1130.</Citation><ArticleIdList><ArticleId IdType="pubmed">34140704</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundes&#xe4;rztekammer. Post-COVID-Syndrom (PCS) Deutsch Arztebl DOI: 10.3238/arztebl.2022.Stellungnahme_PCS (last accessed on 4 January 2023)</Citation></Reference><Reference><Citation>Callard F, Perego E. How and why patients made Long Covid. Soc Sci Med. 2021;268 113426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>AWMF online&#x2014;Das Portal der wissenschaftlichen Medizin. S1-Leitlinie Post-COVID/Long-COVID.  www.awmf.org/uploads/tx_szleitlinien/020-027l_S1_Post_COVID_Long_COVID_2021-07.pdf (last accessed on 21 June 2022) </Citation></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus.  www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (last accessed on 22 June 2022) </Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383:120&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, et al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. 2022;54:1473&#x2013;1487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler CGK, Allon SJ, Nyquist SK, et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020;181:1016&#x2013;1035e19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7252096</ArticleId><ArticleId IdType="pubmed">32413319</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Ibn Hadj Amor H, Jdidi J, et al. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV Study. Front Cardiovasc Med. 2021;8 745758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Martin S, Shchendrygina A, et al. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nat Med. 2022;28:2117&#x2013;2123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556300</ArticleId><ArticleId IdType="pubmed">36064600</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Czaplicki A, Reich H, Hegerl U. Lockdown measures against the spread of the COVID-19 pandemic: negative effects for people living with depression. Front Psychol. 2022;13 789173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8854217</ArticleId><ArticleId IdType="pubmed">35185723</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyungerel B, Paulina S, Justin C, Kylie A, Paul G. Impact of COVID-19 vaccination on long COVID: a systematic review and meta-analysis. Medrxiv. 2022</Citation></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. EClinicalMedicine. 2022;53 101624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28:1461&#x2013;1467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bosworth M. Self-reported long COVID after infection with the Omicron variant in the UK: 18 July 2022: The likelihood of self-reported long COVID after a first coronavirus (COVID-19) infection compatible with the Omicron BA1 or BA.2 variants, compared with the Delta variant, using data from the COVID-19 Infection Survey.  www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/selfreportedlongcovidafterinfectionwiththeomicronvariant/18july2022#toc (last accessed on 26 August 2022) </Citation></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children&#x2014;a nationwide cohort study. Eur J Pediatr. 2022;181:1597&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawke LD, Nguyen ATP, Ski CF, Thompson DR, Ma C, Castle D. Interventions for mental health, cognition, and psychological wellbeing in long COVID: a systematic review of registered trials. Psychol Med. 2022:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9300978</ArticleId><ArticleId IdType="pubmed">35768406</ArticleId></ArticleIdList></Reference><Reference><Citation>Fugazzaro S, Contri A, Esseroukh O, et al. Rehabilitation interventions for post-acute COVID-19 syndrome: a systematic review. Int J Environ Res Public Health. 2022;19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9104923</ArticleId><ArticleId IdType="pubmed">35564579</ArticleId></ArticleIdList></Reference><Reference><Citation>Halabchi F, Selk-Ghaffari M, Tazesh B, Mahdaviani B. The effect of exercise rehabilitation on COVID-19 outcomes: a systematic review of observational and intervention studies. Sport Sci Health. 2022:1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9244056</ArticleId><ArticleId IdType="pubmed">35789736</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandan JS, Brown K, Simms-Williams N, et al. Non-pharmacological therapies for postviral syndromes, including Long COVID: a systematic review and meta-analysis protocol. BMJ Open. 2022;12 e057885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9002258</ArticleId><ArticleId IdType="pubmed">35410933</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira A, Pinto A, Garcia B, Eid RAC, Mol CG, Nawa RK. Telerehabilitation improves physical function and reduces dyspnoea in people with COVID-19 and post-COVID-19 conditions: a systematic review. J Physiother. 2022;68:90&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8994568</ArticleId><ArticleId IdType="pubmed">35414491</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. 2022;377 e069676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>DGKJ-Konvent-Gesellschaften mA. Einheitliche Basisversorgung von Kindern und Jugendlichen mit Long COVID.  https://link.springer.com/content/pdf/10.1007/s00112-021-01408-1.pdf (last accessed on 22 June 2022) </Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00112-021-01408-1.pdf</ArticleId><ArticleId IdType="pmc">PMC9131710</ArticleId><ArticleId IdType="pubmed">35637934</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22:43&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374 n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021;53:737&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Persistent brainstem dysfunction in Long-COVID: a hypothesis. ACS Chem Neurosci. 2021;12:573&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11 e048391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng J, Li Y, Li J, et al. Gastrointestinal sequelae 90 days after discharge for COVID-19. Lancet Gastroenterol Hepatol. 2021;6:344&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7943402</ArticleId><ArticleId IdType="pubmed">33711290</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan S, Khunti K, Alwan N, et al. In the wake of the pandemic: preparing for Long COVID. Copenhagen (Denmark): European Observatory on Health Systems and Policies. 2021</Citation><ArticleIdList><ArticleId IdType="pubmed">33877759</ArticleId></ArticleIdList></Reference><Reference><Citation>Perego E, Balzarini F, Botteri M, et al. Emergency treatment in Lombardy: a new methodology for the pre-hospital drugs management on advanced rescue vehicles. Acta Biomed. 2020;91:111&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7975893</ArticleId><ArticleId IdType="pubmed">32275275</ArticleId></ArticleIdList></Reference><Reference><Citation>Nauen DW, Hooper JE, Stewart CM, Solomon IH. Assessing brain capillaries in coronavirus disease 2019. JAMA Neurol. 2021;78:760&#x2013;762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7881367</ArticleId><ArticleId IdType="pubmed">33576767</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. Afirst step in understanding SARS pathogenesis. J Pathol. 2004;203:631&#x2013;637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi J, Zhou Y, Hua J, et al. The scRNA-seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to SARS-CoV-2 infection. Int J Environ Res Public Health. 2021;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7794913</ArticleId><ArticleId IdType="pubmed">33401657</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Shen W, Rowan NR, et al. Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication. Eur Respir J. 2020 562001948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7439429</ArticleId><ArticleId IdType="pubmed">32817004</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11:995&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F, Maglio M, Landini MP, Fini M. Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2. Front Med (Lausanne) 2020;7 594495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7744810</ArticleId><ArticleId IdType="pubmed">33344479</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M, Freitag H, Rudolf G, et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J Transl Med. 2022;20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B, Ganslmayer M, Lucio M, et al. Retinal microcirculation as a correlate of a systemic capillary impairment after severe acute respiratory syndrome Coronavirus 2 Infection. Front Med (Lausanne) 2021;8 676554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8299003</ArticleId><ArticleId IdType="pubmed">34307408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kresch E, Achua J, Saltzman R, et al. COVID-19 endothelial dysfunction can cause erectile dysfunction: histopathological, immunohistochemical, and ultrastructural study of the human penis. World J Mens Health. 2021;39:466&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8255400</ArticleId><ArticleId IdType="pubmed">33988001</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu KY, Nackeeran S, Horodyski L, Masterson TA, Ramasamy R. COVID-19 infection is associated with new onset Erectile Dysfunction: insights from a national registry. Sex Med. 2022;10 100478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8673874</ArticleId><ArticleId IdType="pubmed">34931145</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Francisco EB, Yogendra R, et al. Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. Front Immunol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, Koch R, Jukic A, et al. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;2:495&#x2013;506e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C, Ferse C, Kreye J, et al. High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms. Brain Behav Immun. 2021;93:415&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834471</ArticleId><ArticleId IdType="pubmed">33359380</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce JD, Shen Q, Cintron SA, Hiebert JB. Post-COVID-19 syndrome. Nurs Res. 2022;71:164&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">34653099</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24:168&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23:194&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Melms JC, Biermann J, Huang H, et al. A molecular single-cell lung atlas of lethal COVID-19. Nature. 2021;595:114&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8814825</ArticleId><ArticleId IdType="pubmed">33915568</ArticleId></ArticleIdList></Reference><Reference><Citation>Witte J, Zeitler A, Batram M, Diekmannshemke J, Hasemann L. Kinder- und Jugendreport 2022: Kinder- und Jugendgesundheit in Zeiten der Pandemie Eine Studie im Auftrag der DAK Gesundheit.  www.dak.de/dak/download/wissenschaftlicher-text-von-dr&#x2013;witte-2572496.pdf (last accessed on 2 September 2022) </Citation></Reference><Reference><Citation>Universit&#xe4;tsklinikum Hamburg-Eppendorf. COPSY-L&#xe4;ngsschnittstudie.  www.uke.de/kliniken-institute/kliniken/kinder-und-jugendpsychiatrie-psychotherapie-und-psychosomatik/forschung/arbeitsgruppen/child-public-health/forschung/copsy-studie.html (last accessed on 2 September 2022) </Citation></Reference><Reference><Citation>Office for National Statistics (ONS) UK. Coronavirus (COVID-19) infection survey, UK 27 May 2022: percentage of people testing positive for coronavirus (COVID-19) in private residential households in England, Wales, Northern Ireland and Scotland, including regional and age breakdowns. / www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/27may2022 (last accessed on 2 September 2022) </Citation></Reference><Reference><Citation>Amalakanti S, Arepalli KVR, Jillella JP. Cognitive assessment in asymptomatic COVID-19 subjects. Virusdisease. 2021;32:146&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7883942</ArticleId><ArticleId IdType="pubmed">33614860</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura ZM, Nash RP, Laughon SL, Rosenstein DL. Neuropsychiatric complications of COVID-19. Curr Psychiatry Rep. 2021;23</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7962429</ArticleId><ArticleId IdType="pubmed">33725218</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Desai AD, Wan EY. Post-COVID-19 condition. Annu Rev Med. 2022</Citation><ArticleIdList><ArticleId IdType="pubmed">35914765</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi Hekmatikar AH, Ferreira Junior JB, Shahrbanian S, Suzuki K. Functional and psychological changes after exercise training in Post-COVID-19 patients discharged from the hospital: a PRISMA-compliant systematic review. Int J Environ Res Public Health. 2022;19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8871540</ArticleId><ArticleId IdType="pubmed">35206483</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Milne A, Samms E, Stadon L, Maskell NA, Hamilton FW. Are vaccines safe in patients with Long COVID? A prospective observational study. Medrxiv. 2021</Citation></Reference><Reference><Citation>Uniklinik K&#xf6;ln. Post-COVID-Sprechstunde.  www.uk-koeln.de/patienten-besucher/post-covid-zentrum/klinische-versorgung-und-ambulanzen/#c9474 (last accessed 02 January 2023) </Citation></Reference><Reference><Citation>LMU Klinikum. Ein Jahr Corona-Pandemie in Deutschland.  www.lmu-klinikum.de/aktuelles/pressemitteilungen/ein-jahr-corona-pandemie-in-deutschland/3dad60a0892ab5a5 (last accessed on 22 June 2022) </Citation></Reference><Reference><Citation>Universit&#xe4;t Regensburg. Anlaufstelle f&#xfc;r junge Menschen mit Long Covid &amp; P&#xe4;diatrischem Multiorgan Immunsyndrom (PMIS)  www.kiss-regensburg.de/nc/aktuelles/detailseite/news/anlaufstelle-fuer-junge-menschen-mit-long-covid-paediatrischem-multiorgan-immunsyndrom-pmis/ (last accessed on 2 September 2022) </Citation></Reference><Reference><Citation>M&#xfc;nchen Klinik Schwabing. Post-Covid-Syndrom (Long Covid) Long Covid Ambulanz: Hilfe bei Covid-Sp&#xe4;tfolgen f&#xfc;r Kinder, Jugendliche und junge Erwachsene bis 18 Jahre.  www.muenchen-klinik.de/krankenhaus/schwabing/kinderkliniken/kinderheilkunde-jugendmedizin/spezialgebiete-kinder-klinik/kinder-immunologie-immunschwaeche-immundefekt/therapie-kinder-immunologie-immundysregulation/long-covid-kinder-jugendliche/ (last accessed on 2 September 2022) </Citation></Reference><Reference><Citation>Universit&#xe4;tsklinikum Carl Gustav Carus Dresden. Long-/Post-COVID-Ambulanz f&#xfc;r Kinder und Jugendliche.  www.uniklinikum-dresden.de/de/das-klinikum/kliniken-polikliniken-institute/kik/bereiche/ambulanzen/anmeldung-postcovid (last accessed on 14 November 2022) </Citation></Reference><Reference><Citation>Universit&#xe4;tsklinikum Jena. Post-/ Long-Covid 19 Ambulanz f&#xfc;r Kinder und Jugendliche ./ www.uniklinikum-jena.de/cscc/Post_COVID_Zentrum/Post_COVID+Ambulanzen/Long_+_+Post_COVID+Ambulanz+Kinder+und+Jugendliche-p-1420.html (last accessed on 9 Januar 2023) </Citation></Reference><Reference><Citation>Charit&#xe9; - Universit&#xe4;tsmedizin Berlin. Post-COVID-Netzwerk der Charit&#xe9; - Universit&#xe4;tsmedizin Berlin.  https://pcn.charite.de/ (last accessed on 7 September 2022) </Citation></Reference><Reference><Citation>Bayerisches Staatsministerium f&#xfc;r Gesundheit und Pflege. Modellprojekt &#x201e;Post-COVID-Kids Bavaria&#x201c;: Teilprojekt 2 &#x201e;Post-COVID-Kids Bavaria&#x2014;PCFC&#x201c; (Post-COVID Fatigue Center)  www.stmgp.bayern.de/wp-content/uploads/2021/10/2021_post-covid-kids-bavaria-2.pdf (last accessed on 22 June 2022) </Citation></Reference><Reference><Citation>Bayerisches Staatsministerium f&#xfc;r Gesundheit und Pflege. Modellprojekt &#x201e;Post-COVID-Kids Bararia&#x201c;: Teilprojekt 1, &#x201e;Post-COVID Kids Bavaria. Langzeitefeffekte von Coronavirusinfektionen bei Kindern und Jugendlichen in Bayern: Erkennung und fr&#xfc;hzeitige Behandlung von Folgeerkrankungen&#x201c;.  www.stmgp.bayern.de/wp-content/uploads/2021/10/2021_post-covid-kids-bavaria-1.pdf (last accessed on 22 June 2022) </Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol. 2021;134:178&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pubmed">33789819</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun. 2022;103:154&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya J-M, Rojas M, Salinas ML, et al. Post-COVID syndrome. A case series and comprehensive review. Autoimmun Rev. 2021;20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, et al. Fatigue and cognitive impairment in Post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;101:93&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics (ONS) UK. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK 2021, 1 April 2021. 
 www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1april2021
 </Citation></Reference><Reference><Citation>Kandemirli SG, Altundag A, Yildirim D, Tekcan Sanli DE, Saatci O. Olfactory bulb MRI and paranasal sinus CT findings in persistent COVID-19 anosmia. Acad Radiol. 2021;28:28&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7571972</ArticleId><ArticleId IdType="pubmed">33132007</ArticleId></ArticleIdList></Reference><Reference><Citation>Konopka KE, Perry W, Huang T, Farver CF, Myers JL. Usual interstitial pneumonia is the most common finding in surgical lung biopsies from patients with persistent interstitial lung disease following infection with SARS-CoV-2. EClinicalMedicine. 2021;42 101209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8609167</ArticleId><ArticleId IdType="pubmed">34841234</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccio U, Zinkernagel AS, Schuepbach R, et al. Long-term persisting SARS-CoV-2 RNA and pathological findings: lessons learnt from a series of 35 COVID-19 autopsies. Front Med (Lausanne) 2022;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8865372</ArticleId><ArticleId IdType="pubmed">35223894</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J-K, Lin S-S, Ji X-J, Guo L-M. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010;47:193&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7088164</ArticleId><ArticleId IdType="pubmed">19333547</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendisch D, Dietrich O, Mari T, et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021;184:6243&#x2013;6261e27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8626230</ArticleId><ArticleId IdType="pubmed">34914922</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from Coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Campion JY, Dudouet P, et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2012;48:2823&#x2013;2833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou MI, Palaiodimou L, Bakola E, et al. Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis. 2022;13 20406223221076890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Guo C, Tang L, et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 2020;5:434&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158584</ArticleId><ArticleId IdType="pubmed">32199469</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone A, Mollaioli D, Limoncin E, et al. The sexual long COVID (SLC): erectile dysfunction as a biomarker of systemic complications for COVID-19 long haulers. Sex Med Rev. 2022;10:271&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8604714</ArticleId><ArticleId IdType="pubmed">34933829</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathmann W, Kuss O, Kostev K. Incidence of newly diagnosed diabetes after Covid-19. Diabetologia. 2022;65:949&#x2013;954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8923743</ArticleId><ArticleId IdType="pubmed">35292829</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>